Production (Stage)
Adaptimmune Therapeutics plc
ADAP
$0.2801
$0.00572.08%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 59.56M | 151.61M | 186.09M | 214.79M | 143.65M |
| Total Receivables | 20.85M | 15.98M | 38.61M | 23.77M | 28.89M |
| Inventory | 11.76M | 7.38M | 1.97M | 1.28M | 1.67M |
| Prepaid Expenses | 7.48M | 10.03M | 14.16M | 10.65M | 9.85M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.35M | 3.17M | 3.38M | 3.29M | 2.84M |
| Total Current Assets | 103.00M | 188.17M | 244.21M | 253.77M | 186.90M |
|
|
|||||
| Total Current Assets | 103.00M | 188.17M | 244.21M | 253.77M | 186.90M |
| Net Property, Plant & Equipment | 48.94M | 51.22M | 65.29M | 64.07M | 67.73M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 3.81M | 3.88M | 4.28M | 996.00K | 524.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.33M | 2.70M | 3.65M | 2.87M | 2.86M |
| Total Assets | 158.07M | 245.96M | 317.44M | 321.70M | 258.01M |
|
|
|||||
| Total Accounts Payable | 5.70M | 8.69M | 9.07M | 7.51M | 6.59M |
| Total Accrued Expenses | 22.22M | 30.90M | 30.34M | 30.74M | 22.41M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.63M | 4.71M | 4.18M | 5.29M | 5.25M |
| Total Finance Division Other Current Liabilities | 18.53M | 20.23M | 19.88M | 38.52M | 32.16M |
| Total Other Current Liabilities | 18.53M | 20.23M | 19.88M | 38.52M | 32.16M |
| Total Current Liabilities | 51.07M | 64.53M | 63.46M | 82.07M | 66.41M |
|
|
|||||
| Total Current Liabilities | 51.07M | 64.53M | 63.46M | 82.07M | 66.41M |
| Long-Term Debt | 25.41M | 50.24M | 49.87M | 24.95M | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 18.67M | 19.26M | 20.46M | 17.10M | 18.44M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 100.35M | 100.09M | 103.67M | 101.30M | 148.78M |
| Total Liabilities | 195.50M | 234.11M | 237.45M | 225.43M | 233.64M |
|
|
|||||
| Common Stock & APIC | 1.11B | 1.11B | 1.10B | 1.10B | 1.10B |
| Retained Earnings | -1.14B | -1.09B | -1.02B | -1.00B | -1.07B |
| Treasury Stock & Other | -4.41M | -1.90M | -5.14M | -3.41M | -2.72M |
| Total Common Equity | -37.43M | 11.85M | 79.99M | 96.27M | 24.38M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -37.43M | 11.85M | 79.99M | 96.27M | 24.38M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -37.43M | 11.85M | 79.99M | 96.27M | 24.38M |
|
|
|||||